Comparative pharmacotherapeutic estimation of different programmes of antiviral therapy of chronic hepatitis C patients treatment
The authors pointed to possibility to chronic hepatitis C patients treatment with the help programmes included recombinant interferons (r-IFN) and characterized reduce cost. The authors noted that such programmes can be used in countries with limited economic resources. In the article are presented data about possibilities to obtain with the help of such programmed the therapeutic effect comparable with effect of programmes included pegylated interferons applicated for the same purpose.